Tetrahedral Framework Nucleic Acids Inhibit Skin Fibrosis via the Pyroptosis Pathway

Area of Science:

• Biomaterials Science
• Dermatology
• Nanotechnology

Background:

• Skin fibrosis results from dysregulated tissue repair following injury or disease.
• Current treatments for skin fibrosis are inadequate and associated with adverse effects.
• There is a need for novel therapies that target fibrosis while minimizing inflammation and cell death.

Purpose of the Study:

• To investigate the therapeutic potential of tetrahedral framework nucleic acids (tFNAs) for skin fibrosis.
• To evaluate the efficacy of tFNAs in inhibiting fibrosis-related cellular processes and pathways.

Main Methods:

• In vitro cell culture experiments and in vivo mouse models were utilized.
• Cells and mice were treated with profibrogenic molecules and tFNAs.
• Key markers of fibrosis, inflammation, and cell death were assessed.

Main Results:

• tFNAs effectively inhibited the epithelial-mesenchymal transition, a key process in fibrosis.
• Treatment with tFNAs led to reduced levels of inflammatory factors.
• tFNAs decreased skin collagen content and inhibited the pyroptosis pathway.

Conclusions:

• tFNAs demonstrate significant antifibrotic effects in vitro and in vivo.
• tFNAs show potential as a novel therapeutic strategy for skin fibrosis.
• These findings suggest tFNAs could be beneficial in treating pyroptosis-related skin conditions.